Paper29947950
Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.
Kim KA and 2 others. Eur J Clin Pharmacol, 2018. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans. Papers, record 29947950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29947950
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytochrome P-450 CYP2D6 | Major topic |
| Cytochrome P-450 CYP3A | Major topic |
| Hemodynamics | Major topic |
| Prostatic Hyperplasia | Major topic |
| Tamsulosin | Major topic |
| Adrenergic alpha-1 Receptor Antagonists | |
| Adult | |
| Biological Availability | |
| Blood Pressure | |
| Humans | |
| Male | |
| Pharmacogenetics | |
| Polymorphism, Genetic |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11740341 | The genetic determinants of the CYP3A5 polymorphism. | Pharmacogenetics | 2001 | https://conductscience.org/library/papers/11740341 | PubMed |
| 2 | 16920322 | Determination of tamsulosin in human aqueous humor and serum by liquid chromatography-electrospray ionization tandem mass spectrometry. | J Pharm Biomed Anal | 2007 | https://conductscience.org/library/papers/16920322 | PubMed |
| 3 | 12485953 | The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin. | Drug Metab Dispos | 2003 | https://conductscience.org/library/papers/12485953 | PubMed |
| 4 | 17213004 | Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study. | Clin Ther | 2006 | https://conductscience.org/library/papers/17213004 | PubMed |
| 5 | 24262967 | Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: a crucial role for the CYP2B6*6 allele. | Clin Chim Acta | 2014 | https://conductscience.org/library/papers/24262967 | PubMed |
| 6 | 24926778 | Functional gene variants of CYP3A4. | Clin Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24926778 | PubMed |
| 7 | 18231117 | Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations. | Clin Pharmacol Ther | 2008 | https://conductscience.org/library/papers/18231117 | PubMed |
| 8 | 24088607 | Recent examples on the clinical relevance of the CYP2D6 polymorphism and endogenous functionality of CYP2D6. | Drug Metabol Drug Interact | 2013 | https://conductscience.org/library/papers/24088607 | PubMed |
| 9 | 17192506 | Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects. | J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17192506 | PubMed |
| 10 | 24192967 | Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology. | BMJ | 2013 | https://conductscience.org/library/papers/24192967 | PubMed |
| 11 | 14647405 | CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers. | Pharmacogenomics J | 2004 | https://conductscience.org/library/papers/14647405 | PubMed |
| 12 | 10431214 | Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. | Trends Pharmacol Sci | 1999 | https://conductscience.org/library/papers/10431214 | PubMed |
| 13 | 8810034 | Absorption, metabolism and excretion of tamsulosin hydrochloride in man. | Xenobiotica | 1996 | https://conductscience.org/library/papers/8810034 | PubMed |
| 14 | 20126606 | Efficacy of alpha-Adrenergic Receptor Blockers in the Treatment of Male Lower Urinary Tract Symptoms. | Rev Urol | 2009 | https://conductscience.org/library/papers/20126606 | PubMed |
| 15 | 8973992 | Pharmacokinetics of tamsulosin hydrochloride in patients with renal impairment: effects of alpha 1-acid glycoprotein. | J Clin Pharmacol | 1996 | https://conductscience.org/library/papers/8973992 | PubMed |
| 16 | 11279519 | Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. | Nat Genet | 2001 | https://conductscience.org/library/papers/11279519 | PubMed |
| 17 | 16986050 | Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia. | Rev Urol | 2005 | https://conductscience.org/library/papers/16986050 | PubMed |
| 18 | 15220015 | Randomized, open-label, two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects. | Clin Ther | 2004 | https://conductscience.org/library/papers/15220015 | PubMed |
| 19 | 19744012 | Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients. | J Clin Pharm Ther | 2009 | https://conductscience.org/library/papers/19744012 | PubMed |
| 20 | 25073735 | Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms. | Expert Opin Drug Saf | 2014 | https://conductscience.org/library/papers/25073735 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42474264 | Pharmacokinetics and Bioequivalence of Tamsulosin Hydrochloride Extended-Release Capsules in Healthy Chinese Volunteers: A Randomized, Open-Label, Crossover Study Under Fasting and Fed Conditions. | Clin Pharmacol Drug Dev | 2026 | https://conductscience.org/library/papers/42474264 | PubMed |
| 42367398 | Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete. | Cureus | 2026 | https://conductscience.org/library/papers/42367398 | PubMed |
| 40863448 | Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management. | J Pers Med | 2025 | https://conductscience.org/library/papers/40863448 | PubMed |
| 40467447 | [Androgen receptor-targeted therapies - avoid clinically relevant interactions]. | Aktuelle Urol | 2026 | https://conductscience.org/library/papers/40467447 | PubMed |
| 34751931 | Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele. | Arch Pharm Res | 2021 | https://conductscience.org/library/papers/34751931 | PubMed |
| 34690761 | Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34690761 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP2D6 | 1565 | PubTator's text mining | https://conductscience.org/library/genes/1565 | NCBI Gene |
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| CYP3A5 | 1577 | PubTator's text mining | https://conductscience.org/library/genes/1577 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29947950
GET https://conductscience.org/api/papers/v1/29947950/references?page=2